← FDA Drug Approvals (Drugs@FDA)
SUFLAVE
NDA · New Drug Application · Sponsor: AZURITY · Approved 2023-06-15
Drug application
- FDA Application #
NDA215344- Application type
- New Drug Application
- Brand name
- SUFLAVE
- Generic name
- POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, AND SODIUM CHLORIDE FOR ORAL SOLUTION
- Active ingredients
- MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM SULFATE
- Dosage form
- FOR SOLUTION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AZURITY
- Manufacturer
- Braintree Laboratories, Inc.
- First approval
- 2023-06-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown